<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="was revealed to be the cause of COVID19, the pandemic" exact="disease" post="that already provoked more than 555.324 deaths in the"/>
 <result pre="classification, the source, the action, the specific target in the" exact="viral infection." post="Our aim was to collect possible compounds for prevention"/>
 <result pre="Key findings and conclusions The definition of appropriate interventions against" exact="viral" post="diseases need a comprehensive view on the infection dynamics"/>
 <result pre="interventions against viral diseases need a comprehensive view on the" exact="infection" post="dynamics and on necessary treatments. Viral targeting compounds to"/>
 <result pre="comprehensive view on the infection dynamics and on necessary treatments." exact="Viral" post="targeting compounds to be exploited in food sciences could"/>
 <result pre="resource. Keywords SARS MERS Antiviral compounds-natural products Web based resource" exact="Viral" post="fight 1 Introduction 1.1 Natural products as source of"/>
 <result pre="and well-being. NPs are divided in two main groups: the" exact="primary" post="and the secondary metabolites. Primary metabolites are ubiquitous organic"/>
 <result pre="are divided in two main groups: the primary and the" exact="secondary" post="metabolites. Primary metabolites are ubiquitous organic compounds considered essential"/>
 <result pre="in two main groups: the primary and the secondary metabolites." exact="Primary" post="metabolites are ubiquitous organic compounds considered essential for the"/>
 <result pre="the organism life, including nucleic acids, proteins, carbohydrates, and lipids." exact="Secondary" post="metabolites are instead organic compounds, with a much more"/>
 <result pre="Secondary metabolites are instead organic compounds, with a much more" exact="limited" post="distribution in nature, that sustain the structure and the"/>
 <result pre="status of cells and overall organisms (Pietra, 1997). In particular," exact="secondary" post="metabolites such as flavonoids (Pietta, 2000), alkaloids (Cordell et"/>
 <result pre="2005), or act on components involved in specific diseases, like" exact="hypertension" post="(Balasuriya &amp;amp; Rupasinghe, 2010). For their broad spectrum of"/>
 <result pre="for their effects on multifactorial diseases, such as neurodegeneration and" exact="cancer" post="(Balunas &amp;amp; Kinghorn, 2005). For example, the alkaloid colchicine,"/>
 <result pre="such as high temperatures, extreme pH, high salt concentrations, and/or" exact="high pressure." post="For example, the thermostable beta-glucosidase enzyme of Pyrococcus furiosus"/>
 <result pre="from Aspergillus terreus, is important for the production of anti" exact="atherosclerosis" post="drugs (statins) (Subhan et al., 2016). Animals also represent"/>
 <result pre="Ecteinascidia turbinata). The former is used to relieve severe and" exact="chronic" post="pain, whereas, the latter is used to treat cancer"/>
 <result pre="and chronic pain, whereas, the latter is used to treat" exact="cancer" post="(Lobo-Ruiz &amp;amp; Tulla-Puche, 2018). Marine organisms are also of"/>
 <result pre="xylomannan sulphate (from Nothogenia fastigiata) exhibit antiviral activity against human" exact="immunodeficiency" post="virus, herpes simplex viruses types 1, 2 and respiratory"/>
 <result pre="(from Nothogenia fastigiata) exhibit antiviral activity against human immunodeficiency virus," exact="herpes" post="simplex viruses types 1, 2 and respiratory syncytial virus"/>
 <result pre="human immunodeficiency virus, herpes simplex viruses types 1, 2 and" exact="respiratory" post="syncytial virus (Pal et al., 2014). Several NPs extracted"/>
 <result pre="2014). Several NPs extracted from plants were proven effective against" exact="viral" post="infections, including those from coronaviruses (CoVs), coxsackieviruses, enterovirus 71,"/>
 <result pre="infections, including those from coronaviruses (CoVs), coxsackieviruses, enterovirus 71, dengue," exact="hepatitis" post="B, hepatitis C, herpes simplex, human immunodeficiency (HIV-1) and"/>
 <result pre="those from coronaviruses (CoVs), coxsackieviruses, enterovirus 71, dengue, hepatitis B," exact="hepatitis C," post="herpes simplex, human immunodeficiency (HIV-1) and influenza viruses (Lin"/>
 <result pre="coronaviruses (CoVs), coxsackieviruses, enterovirus 71, dengue, hepatitis B, hepatitis C," exact="herpes" post="simplex, human immunodeficiency (HIV-1) and influenza viruses (Lin et"/>
 <result pre="enterovirus 71, dengue, hepatitis B, hepatitis C, herpes simplex, human" exact="immunodeficiency" post="(HIV-1) and influenza viruses (Lin et al., 2014). For"/>
 <result pre="(HIV-1) and influenza viruses (Lin et al., 2014). For example," exact="secondary" post="metabolites from green tea (Steinmann et al., 2013), cinnamon"/>
 <result pre="action against different viruses (HIV-1, human papillomavirus, hepatitis, influenza, chikungunya," exact="herpes" post="simplex 2, and Zika viruses (ZIKV)). In the past"/>
 <result pre="three epidemic diseases: SARS-CoV2 (Zhou et al., 2020), the severe" exact="acute" post="respiratory syndrome (SARS) (Rota et al., 2003) and the"/>
 <result pre="epidemic diseases: SARS-CoV2 (Zhou et al., 2020), the severe acute" exact="respiratory" post="syndrome (SARS) (Rota et al., 2003) and the Middle"/>
 <result pre="diseases: SARS-CoV2 (Zhou et al., 2020), the severe acute respiratory" exact="syndrome" post="(SARS) (Rota et al., 2003) and the Middle East"/>
 <result pre="syndrome (SARS) (Rota et al., 2003) and the Middle East" exact="respiratory" post="syndrome (MERS) (Zaki et al., 2012). They have been,"/>
 <result pre="(SARS) (Rota et al., 2003) and the Middle East respiratory" exact="syndrome" post="(MERS) (Zaki et al., 2012). They have been, and"/>
 <result pre="to be, a threat to human lives, mainly triggering severe" exact="infections" post="that are the leading causes of death, as communicated"/>
 <result pre="SARS-CoV2 raised again the problem of suitable treatments against dangerous" exact="viral" post="infections and of appropriate care. Despite advances in immunization"/>
 <result pre="raised again the problem of suitable treatments against dangerous viral" exact="infections" post="and of appropriate care. Despite advances in immunization and"/>
 <result pre="effective preventive vaccine or efficient antiviral therapies to treat coronavirus" exact="infection" post="diseases and to limit the main cause of death"/>
 <result pre="or relief the effects of the human response to the" exact="infection" post="is of fundamental importance for fighting COVID19 and similar"/>
 <result pre="They can infect also other animals, like birds and mammals." exact="Alpha" post="and beta coronaviruses are of particular interest because these"/>
 <result pre="divided into four different lineages based on their genomic characterization." exact="Alpha" post="coronaviruses, including the strains 229E and NL63; beta coronaviruses"/>
 <result pre="Eaton, 2007). Moreover, the same event happened with Middle East" exact="respiratory" post="syndrome (MERS-CoV), that started in 2015, when another beta"/>
 <result pre="2007). Moreover, the same event happened with Middle East respiratory" exact="syndrome" post="(MERS-CoV), that started in 2015, when another beta coronavirus,"/>
 <result pre="the seven conserved domains in the ORF1ab, coding for the" exact="viral" post="replicases, that is in general used to classify CoV"/>
 <result pre="Wang, 2020). In humans, coronaviruses can generate diseases ranging from" exact="upper" post="respiratory tract infections to severe acute respiratory syndrome (SARS),"/>
 <result pre="2020). In humans, coronaviruses can generate diseases ranging from upper" exact="respiratory" post="tract infections to severe acute respiratory syndrome (SARS), causing"/>
 <result pre="humans, coronaviruses can generate diseases ranging from upper respiratory tract" exact="infections" post="to severe acute respiratory syndrome (SARS), causing death. In"/>
 <result pre="generate diseases ranging from upper respiratory tract infections to severe" exact="acute" post="respiratory syndrome (SARS), causing death. In particular, the high"/>
 <result pre="diseases ranging from upper respiratory tract infections to severe acute" exact="respiratory" post="syndrome (SARS), causing death. In particular, the high mortality"/>
 <result pre="ranging from upper respiratory tract infections to severe acute respiratory" exact="syndrome" post="(SARS), causing death. In particular, the high mortality rates"/>
 <result pre="attention versus SARS and MERS epidemic events (SARS caused a" exact="total" post="of 774 patients died on 8096 diagnosed patients (total"/>
 <result pre="mortality rate, 9.6%) (Keum &amp;amp; Jeong, 2012). For MERS a" exact="total" post="of 652 patients died on 1842 diagnosed patients (total"/>
 <result pre="with SARS-CoV and MERS-CoV, are the major causes of severe" exact="pneumonia" post="in humans caused by Coronaviridae. They all share common"/>
 <result pre="2020). PLPro also takes part in this process, acting on" exact="secondary" post="cleavage sites on PP1a and PP1ab. These events produce"/>
 <result pre="events produce the two replicases and other enzymes involved in" exact="viral" post="transcription and replication, including an RNA dependant RNA polymerase"/>
 <result pre="al., 2016). The N protein functions primarily by binding the" exact="viral" post="genome and organizing it as a nucleocapsid. Putatively, it"/>
 <result pre="protein defines the shape of the envelope, promotes the final" exact="viral" post="assembly, and together with the E protein forms the"/>
 <result pre="protein forms the envelope. The E protein is the smallest" exact="viral" post="protein inside the infected cells, but only a small"/>
 <result pre="et al., 2020). Because of its role in starting the" exact="viral infection," post="the S proteins are particularly of interest since they"/>
 <result pre="of interest since they also determine the efficiency of the" exact="infection" post="and its spreading (Zhou et al., 2020). Spike proteins"/>
 <result pre="S protein priming, and that is crucial to determine the" exact="viral" post="entry into the cell (Zhou et al., 2020). Fig."/>
 <result pre="cycle Although the processes causing HCoVs entry into cells and" exact="viral" post="particles formation still require deeper investigations, we here summarize"/>
 <result pre="or simply via membrane fusion, and the release of the" exact="viral" post="genome into the cytosol appears to take place through"/>
 <result pre="the cytosol appears to take place through acidification. Subsequently, the" exact="viral" post="RNA overlapping ORFs forming the ORF1ab are translated, exploiting"/>
 <result pre="replication process. The replication process gives rise to a full-length" exact="viral" post="RNA genome which functions as a template for the"/>
 <result pre="RNA genome which functions as a template for the new" exact="viral" post="genomes and for subgenomic RNAs coding for viral structural"/>
 <result pre="the new viral genomes and for subgenomic RNAs coding for" exact="viral" post="structural proteins (Bergmann et al., 2006). Here copies of"/>
 <result pre="structural proteins (Bergmann et al., 2006). Here copies of the" exact="viral" post="genome, forming the nucleocapside with the N proteins, contribute"/>
 <result pre="(Table S1). To this end, they performed anti-HCoV assays infecting" exact="viral" post="susceptible MRC-5 fibroblast cells from lung, treating them with"/>
 <result pre="on different viruses. In particular, tetrandrine (TET) has effect on" exact="herpes" post="simplex and dengue viruses (Hu et al., 1997; Liou"/>
 <result pre="(CEP), possesses anti-viral activity against HIV-1 (Baba et al., 2001)," exact="herpes" post="simplex (Liu et al., 2004) and Ebola viruses (Sakurai"/>
 <result pre="suppressed the expression of S and N proteins and the" exact="viral" post="replication (Kim et al., 2019). In particular, the authors"/>
 <result pre="compounds had high antiviral activity from 3Â h before the" exact="infection" post="with HCoV-OC43. On the other hand, the treatments at"/>
 <result pre="Moreover, the authors investigated the effects of the compounds on" exact="viral" post="replication. They quantified the abundance of viruses in the"/>
 <result pre="role of resveratrol against SARS-CoV, but also positive effects against" exact="bacterial infections," post="only reduced in case of Helicobacter pilory (Zhang et"/>
 <result pre="MERS-CoV) (Raj et al., 2013) in mouse and tested mouse" exact="infection" post="by MERS-CoV. They treated infected mouse with resveratrol and"/>
 <result pre="from Broussonetia papyrifera against MERS/SARS-CoV proteases. The authors expressed the" exact="viral" post="3CL and PLpro in E. coli and performed an"/>
 <result pre="in E. coli and performed an inhibition assay to evaluate" exact="viral" post="proteases activity after exposure to 10 plant root derived"/>
 <result pre="authors suggested the baicalin for both prophylaxis or treatment SARS-CoV" exact="infectious disease." post="The intravenous administration of a 360Â mg dose of"/>
 <result pre="known, regarding HIV-1 infections, baicalin was shown to inhibit the" exact="infection" post="process both at cellular entry and through the inhibition"/>
 <result pre="300Â mg/L) was obtained when administered during and after the" exact="viral" post="adsorption in Vero E6 cells, the African green monkey"/>
 <result pre="and after the viral adsorption in Vero E6 cells, the" exact="African" post="green monkey kidney cell line. Despite the glycyrrhizin had"/>
 <result pre="the concentrations of P24 antigen and prevented the development of" exact="hepatocellular carcinoma" post="in those infected by HIV-1 and chronic hepatitis C"/>
 <result pre="concentrations of P24 antigen and prevented the development of hepatocellular" exact="carcinoma" post="in those infected by HIV-1 and chronic hepatitis C"/>
 <result pre="development of hepatocellular carcinoma in those infected by HIV-1 and" exact="chronic hepatitis C" post="virus, respectively (Busia, 2017). Since side-effects were reported after"/>
 <result pre="of hepatocellular carcinoma in those infected by HIV-1 and chronic" exact="hepatitis C" post="virus, respectively (Busia, 2017). Since side-effects were reported after"/>
 <result pre="the authors suggested that the treatments should last for a" exact="short" post="period. Despite the mechanism of the antiviral activity against"/>
 <result pre="an inhibitor of SARS-CoV replication. Results on the inhibition of" exact="viral" post="adsorption were also found by Keyaerts et al., in"/>
 <result pre="et al. (Keum &amp;amp; Jeong, 2012) analyzed the activity of" exact="viral" post="helicase. Firstly, they focused on the DNA unwinding activity"/>
 <result pre="compounds that inhibit the DNA unwinding activity. They mixed the" exact="viral" post="helicase protein with fluorescent-labeled double stranded DNA, each strand"/>
 <result pre="lost as soon as the duplex is unwound by the" exact="viral" post="helicase. Using this experimental approach, they excluded that the"/>
 <result pre="they screened) interfered with the DNA unwinding activity of the" exact="viral" post="helicase protein. Subsequently, they examined the possible effects of"/>
 <result pre="64 natural compounds on the suppression of ATP hydrolysis by" exact="viral" post="helicase. The ATP hydrolysis activity of viral helicase was"/>
 <result pre="ATP hydrolysis by viral helicase. The ATP hydrolysis activity of" exact="viral" post="helicase was measured using a long circular ssDNA as"/>
 <result pre="measured using a long circular ssDNA as a template. The" exact="viral" post="helicase protein is expected to continuously translocate along the"/>
 <result pre="flavonoids, myricetin and scutellarein, inhibited the ATPase activity of the" exact="viral" post="helicase (IC50 values: 2.71Â Â±Â 0.19Â Î¼M and 0.86Â"/>
 <result pre="Î¼M and 0.86Â Â±Â 0.48Â Î¼M, respectively), thus impacting on" exact="viral" post="replication (Keum &amp;amp; Jeong, 2012). In 2014, Sun et"/>
 <result pre="RNA cap guanine-N7-methyltransferase) indicating its possible useful effect on the" exact="viral" post="replication and subgenome expression (Sun et al., 2014). Wu"/>
 <result pre="an immunofluorescence assay to identify the presence of antibodies against" exact="viral" post="antigens and with flow cytometry though the analysis of"/>
 <result pre="the analysis of a decrease in the level of the" exact="viral" post="spike protein. Looking for others active compounds in their"/>
 <result pre="over 200 medicinal herbs, that were reported as useful against" exact="viral infection," post="looking for possible anti SARS-CoV medicaments. They infected Vero"/>
 <result pre="E6 and HepG2 cells, an immortal cell line derived from" exact="hepatocellular carcinoma," post="with two different strains of SARS-CoV (BJ001, BJ006). They"/>
 <result pre="by the virus. After the addition of active compounds, the" exact="viral infection" post="and replication was sharply reduced resulting in and increased"/>
 <result pre="the virus. After the addition of active compounds, the viral" exact="infection" post="and replication was sharply reduced resulting in and increased"/>
 <result pre="PLpro, they measured SARS-CoV PLpro activity in the presence or" exact="absence of" post="test compounds using a fluorogenic assay. The SARS-CoV PLpro"/>
 <result pre="of actionâ€�, â€œadverse effectsâ€�, and â€œclinical approvalsâ€�, yielding to a" exact="total" post="of 30 drugs (Li et al., 2020). From their"/>
 <result pre="exact correspondence (Table 1b), so that we could report the" exact="complete" post="list also in Table S1. Specifically, starting from the"/>
 <result pre="and predicted their structures by homology modeling. They identified a" exact="total" post="of 21 targets (19 viral and 2 human targets)"/>
 <result pre="homology modeling. They identified a total of 21 targets (19" exact="viral" post="and 2 human targets) that were screened against an"/>
 <result pre="from a dosing site, the distribution to target and other" exact="systemic" post="and peripheral tissues, and the elimination of unchanged drug"/>
 <result pre="dosing site, the distribution to target and other systemic and" exact="peripheral" post="tissues, and the elimination of unchanged drug by metabolism"/>
 <result pre="absence in two different species is strongly predictive of the" exact="absence of" post="toxicity in humans. In general, human adverse drug reaction"/>
 <result pre="human adverse drug reaction (ADR) is associated mainly to hepatic," exact="cardiovascular" post="and neurological toxicities (Olson et al., 2000). Drug-drug interaction"/>
 <result pre="-and vitamin C (60Â mg/ml) in micellar formulation against SARS-CoV2" exact="infections" post="(Table S1). Moreover, on May 19th a clinical trails"/>
 <result pre="The aim is the slowing down the progress of the" exact="disease" post="and therefore the improvement of patientsâ€™ prognosis. All the"/>
 <result pre="Discussion Despite advances in prevention, immunotherapy and drug development, some" exact="infectious diseases" post="still require effective vaccines or efficient antiviral therapies. As"/>
 <result pre="food design is of fundamental importance to fight the COVID19" exact="disease" post="and all its side effects, to be ready for"/>
 <result pre="(Orlikova et al., 2014), providing useful tools for treatments of" exact="infectious disease" post="(Balunas &amp;amp; Kinghorn, 2005). NPs can target pathogen-host interaction"/>
 <result pre="et al., 2014), providing useful tools for treatments of infectious" exact="disease" post="(Balunas &amp;amp; Kinghorn, 2005). NPs can target pathogen-host interaction"/>
 <result pre="and of being effective on one or more phases determining" exact="viral" post="absorption and replication (Fig. 1) (de Wit et al.,"/>
 <result pre="relevant information and annotating the specific targets according to the" exact="viral" post="replication cycle, when known, as well as the compound"/>
 <result pre="and sinefungin from Streptomyces. All compounds were classified to be" exact="secondary" post="metabolites, with major classes being represented by Flavonoids (48"/>
 <result pre="Quinones (2 compounds). In Fig. 2 , we summarized the" exact="total" post="amount of different classes per viral life cycle phase,"/>
 <result pre=", we summarized the total amount of different classes per" exact="viral" post="life cycle phase, also highlighting the classes representing the"/>
 <result pre="no active compounds were revealed for phases 2 (release of" exact="viral" post="genome) and 3 (translation of polyproteins). All the details"/>
 <result pre="accessible resource (https://bigdatainhealth.org/letsbe/anti-HCoV.php). Fig. 2 Number of chemical classes per" exact="viral" post="life cycle phases. Among the different phases, as an"/>
 <result pre="different phases, as an example, phase 1 (receptor binding and" exact="viral" post="entry) is the most critical for the overall infective"/>
 <result pre="and viral entry) is the most critical for the overall" exact="infective" post="process (Fig. 1). Among the different events that occur"/>
 <result pre="could reveal the effective multi target action of harmonyl against" exact="viral" post="replication. All the remaining compounds and target phases can"/>
 <result pre="proper food selection and design because of their action against" exact="viral" post="absorption and replication. We annotated those that were in"/>
 <result pre="by computational analysis. We highlighted the action in the different" exact="viral" post="life cycle phases also to identify compounds that could"/>
 <result pre="of SOCS-1: Role in apoptosis induction and radiosensitization in head" exact="and neck" post="tumor cellsPhytomedicine: International Journal of Phytotherapy and Phytopharmacology235201656657710.1016/j.phymed.2016.02.01127064016 BalasuriyaN.RupasingheH.P.V.Plant"/>
 <result pre="Role in apoptosis induction and radiosensitization in head and neck" exact="tumor" post="cellsPhytomedicine: International Journal of Phytotherapy and Phytopharmacology235201656657710.1016/j.phymed.2016.02.01127064016 BalasuriyaN.RupasingheH.P.V.Plant flavonoids"/>
 <result pre="Foods Health Dis5201010.31989/ffhd.v1i5.132 BalunasM.J.KinghornA.D.Drug discovery from medicinal plantsLife Sciences785200543144110.1016/j.lfs.2005.09.01216198377 BergmannC.LaneT.StohlmanS.Coronavirus" exact="infection" post="of the central nervous system: Host-virus stand-offNature Reviews Microbiology4200612113210.1038/nrmicro134316415928"/>
 <result pre="the 2019 novel human-pathogenic coronavirus isolated from a patient with" exact="atypical pneumonia" post="after visiting WuhanEmerging Microbes &amp;amp; Infections91202022123610.1080/22221751.2020.171990231987001 ChenF.ChanK.H.JiangY.KaoR.Y.T.LuH.T.FanK.W.ChengV.C.C.TsuiW.H.W.HungI.F.N.LeeT.S.W.GuanY.PeirisJ.S.M.YuenK.Y.In vitro susceptibility"/>
 <result pre="2019 novel human-pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting WuhanEmerging Microbes &amp;amp; Infections91202022123610.1080/22221751.2020.171990231987001 ChenF.ChanK.H.JiangY.KaoR.Y.T.LuH.T.FanK.W.ChengV.C.C.TsuiW.H.W.HungI.F.N.LeeT.S.W.GuanY.PeirisJ.S.M.YuenK.Y.In vitro susceptibility"/>
 <result pre="compoundsJournal of Clinical Virology: The Official Publication of the Pan" exact="American" post="Society for Clinical Virology3112004697510.1016/j.jcv.2004.03.00315288617 ChenL.LiJ.LuoC.LiuH.XuW.ChenG.LiewO.W.ZhuW.PuahC.M.ShenX.JiangH.Binding interaction of quercetin-3-beta-galactoside and"/>
 <result pre="isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human" exact="colon cancer" post="cellsCancer Research60520001426143310728709 GaoQ.YuanY.GanH.-Z.PengQ.Resveratrol inhibits the hedgehog signaling pathway and"/>
 <result pre="induces cell cycle arrest and apoptosis in HT29 human colon" exact="cancer" post="cellsCancer Research60520001426143310728709 GaoQ.YuanY.GanH.-Z.PengQ.Resveratrol inhibits the hedgehog signaling pathway and"/>
 <result pre="inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses" exact="gastric cancer" post="invasion and metastasisOncology Letters9520152381238710.3892/ol.2015.298826137075 GohJ.-Y.WeaverR.J.DixonL.PlattN.J.RobertsR.A.Development and use of in"/>
 <result pre="the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric" exact="cancer" post="invasion and metastasisOncology Letters9520152381238710.3892/ol.2015.298826137075 GohJ.-Y.WeaverR.J.DixonL.PlattN.J.RobertsR.A.Development and use of in"/>
 <result pre="pharmaceuticals2009ICH, European Medicines Agency HarveyA.L.CreeI.A.High-throughput screening of natural products for" exact="cancer" post="therapyPlanta Medica761120101080108610.1055/s-0030-125016220635309 HoffmannM.Kleine-WeberH.SchroederS.KrÃ¼gerN.HerrlerT.ErichsenS. â€¦PÃ¶hlmannS.SARS-CoV-2 cell entry depends on ACE2"/>
 <result pre="blocked by a clinically proven protease inhibitorCell1812202027128010.1016/j.cell.2020.02.05232142651 HuS.DuttJ.ZhaoT.FosterC.S.Tetrandrine potently inhibits" exact="herpes" post="simplex virus type-1-induced keratitis in BALB/c miceOcular Immunology and"/>
 <result pre="proven protease inhibitorCell1812202027128010.1016/j.cell.2020.02.05232142651 HuS.DuttJ.ZhaoT.FosterC.S.Tetrandrine potently inhibits herpes simplex virus type-1-induced" exact="keratitis" post="in BALB/c miceOcular Immunology and Inflammation53199717318010.3109/092739497091168929326762 IslamM.SarkarC.El-KershD.JamaddarS.UddinS.ShilpiJ.MubarakM.Natural products and"/>
 <result pre="and preâ€�clinical dataPhytotherapy Research202012210.1002/ptr.6700 KaplanM.M.AllingD.W.ZimmermanH.J.WolfeH.J.SeperskyR.A.HirschG.S.EltaG.H.GlickK.A.EagenK.A.A prospective trial of colchicine for" exact="primary" post="biliary cirrhosisNew England Journal of Medicine3152319861448145410.1056/NEJM1986120431523043537784 KeumY.-S.JeongY.-J.Development of chemical"/>
 <result pre="of Medicine3152319861448145410.1056/NEJM1986120431523043537784 KeumY.-S.JeongY.-J.Development of chemical inhibitors of the SARS coronavirus:" exact="Viral" post="helicase as a potential targetBiochemical Pharmacology841020121351135810.1016/j.bcp.2012.08.01222935448 KeyaertsE.VijgenL.PannecouqueC.Van DammeE.PeumansW.EgberinkH.BalzariniJ.Van RanstM.Plant"/>
 <result pre="inhibitors of coronaviruses by interfering with two targets in the" exact="viral" post="replication cycleAntiviral Research753200717918710.1016/j.antiviral.2007.03.00317428553 KimD.E.MinJ.S.JangM.S.LeeJ.Y.ShinY.S.SongJ.H.KimH.R.KimS.JinY.-H.KwonS.Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine,"/>
 <result pre="KimD.E.MinJ.S.JangM.S.LeeJ.Y.ShinY.S.SongJ.H.KimH.R.KimS.JinY.-H.KwonS.Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43" exact="infection" post="of MRC-5 human lung cellsBiomolecules911201910.3390/biom9110696 KorkinaL.KostyukV.De LucaC.PastoreS.Plant phenylpropanoids as"/>
 <result pre="Chemistry1110201182383510.2174/13895571179657548921762105 LiW.CaoL.ChenX.LeiJ.MaQ.Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of" exact="pancreatic cancer" post="cells via suppression of the Hedgehog signaling pathwayOncology Reports35320161718172610.3892/or.2015.450426707376"/>
 <result pre="LiW.CaoL.ChenX.LeiJ.MaQ.Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic" exact="cancer" post="cells via suppression of the Hedgehog signaling pathwayOncology Reports35320161718172610.3892/or.2015.450426707376"/>
 <result pre="antiviral activities against SARS-associated coronavirusAntiviral Research6712005182310.1016/j.antiviral.2005.02.00715885816 LinS.-C.HoC.-T.ChuoW.-H.LiS.WangT.T.LinC.-C.Effective inhibition of MERS-CoV" exact="infection" post="by resveratrolBMC Infectious Diseases171201714410.1186/s12879-017-2253-828193191 LinL.-T.HsuW.-C.LinC.-C.Antiviral natural products and herbal"/>
 <result pre="SARS-associated coronavirusAntiviral Research6712005182310.1016/j.antiviral.2005.02.00715885816 LinS.-C.HoC.-T.ChuoW.-H.LiS.WangT.T.LinC.-C.Effective inhibition of MERS-CoV infection by resveratrolBMC" exact="Infectious" post="Diseases171201714410.1186/s12879-017-2253-828193191 LinL.-T.HsuW.-C.LinC.-C.Antiviral natural products and herbal medicinesJournal of Traditional"/>
 <result pre="Integrative Biology44201138238410.4161/cib.4.4.1530921966552 LiuX.WangY.ZhangM.LiG.CenY.[Study on the inhibitory effect of cepharanthine on" exact="herpes" post="simplex type-1 virus (HSV-1) in vitro]Zhong yao cai ="/>
 <result pre="medicinal materials272200410711022454997 LiuY.ZhouJ.QuY.YangX.ShiG.WangX.HongY.DrlicaK.ZhaoX.Resveratrol antagonizes antimicrobial lethality and stimulates recovery of" exact="bacterial" post="mutantsPloS One1142016e015302310.1371/journal.pone.0153023 LiB.WangZ.LiS.DonelanW.WangX.CuiT.TangD.Preparation of lactose-free pasteurized milk with a"/>
 <result pre="Journal1201410.4236/oalib.1100752 ParkJ.-Y.JeongH.KimJ.KimY.ParkS.C.KimD.ParkK.LeeW.RyuY.Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe" exact="acute" post="respiratory syndrome coronavirusBiological and Pharmaceutical Bulletin35201210.1248/bpb.b12-00623 ParkJ.-Y.YukH.J.RyuH.W.LimS.H.KimK.S.ParkK.H.RyuY.B.LeeW.S.Evaluation of polyphenols"/>
 <result pre="ParkJ.-Y.JeongH.KimJ.KimY.ParkS.C.KimD.ParkK.LeeW.RyuY.Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute" exact="respiratory" post="syndrome coronavirusBiological and Pharmaceutical Bulletin35201210.1248/bpb.b12-00623 ParkJ.-Y.YukH.J.RyuH.W.LimS.H.KimK.S.ParkK.H.RyuY.B.LeeW.S.Evaluation of polyphenols from"/>
 <result pre="from Alnus japonica inhibit papain-like protease of severe acute respiratory" exact="syndrome" post="coronavirusBiological and Pharmaceutical Bulletin35201210.1248/bpb.b12-00623 ParkJ.-Y.YukH.J.RyuH.W.LimS.H.KimK.S.ParkK.H.RyuY.B.LeeW.S.Evaluation of polyphenols from Broussonetia"/>
 <result pre="daMartinsM.K.AzevedoJ. L. deAraÃºjoJ. M. deAntibiotics produced by StreptomycesBrazilian Journal of" exact="Infectious" post="Diseases: An Official Publication of the Brazilian Society of"/>
 <result pre="StreptomycesBrazilian Journal of Infectious Diseases: An Official Publication of the" exact="Brazilian" post="Society of Infectious Diseases165201246647110.1016/j.bjid.2012.08.014 PyrcK.BoschB.J.BerkhoutB.JebbinkM.F.DijkmanR.RottierP.van der HoekL.Inhibition of human"/>
 <result pre="Infectious Diseases: An Official Publication of the Brazilian Society of" exact="Infectious" post="Diseases165201246647110.1016/j.bjid.2012.08.014 PyrcK.BoschB.J.BerkhoutB.JebbinkM.F.DijkmanR.RottierP.van der HoekL.Inhibition of human coronavirus NL63 infection"/>
 <result pre="of Infectious Diseases165201246647110.1016/j.bjid.2012.08.014 PyrcK.BoschB.J.BerkhoutB.JebbinkM.F.DijkmanR.RottierP.van der HoekL.Inhibition of human coronavirus NL63" exact="infection" post="at early stages of the replication cycleAntimicrobial Agents and"/>
 <result pre="from the rhizomes of Swertia speciosaChemistry and Biodiversity21020051310131510.1002/cbdv.20059010217191931 ReedD.RainaK.AgarwalR.Nutraceuticals in" exact="prostate cancer" post="therapeutic strategies and their neo-adjuvant use in diverse populationsNPJ"/>
 <result pre="the rhizomes of Swertia speciosaChemistry and Biodiversity21020051310131510.1002/cbdv.20059010217191931 ReedD.RainaK.AgarwalR.Nutraceuticals in prostate" exact="cancer" post="therapeutic strategies and their neo-adjuvant use in diverse populationsNPJ"/>
 <result pre="Today231220181925192810.1016/j.drudis.2018.05.02829803936 RotaP.A.ObersteM.S.MonroeS.S.NixW.A.CampagnoliR.IcenogleJ.P.PeÃ±arandaS.BankampB.MaherK.ChenM.-H.TongS.TaminA.LoweL.FraceM.DeRisiJ.L.ChenQ.WangD.ErdmanD.D.PeretT.C.T. â€¦BelliniW.J.Characterization of a novel coronavirus associated with severe" exact="acute" post="respiratory syndromeScience (New York, N.Y.)300562420031394139910.1126/science.1085952 SaitoA.Y.Marin RodriguezA.A.Menchaca VegaD.S.SussmannR.A.C.KimuraE.A.KatzinA.M.Antimalarial activity"/>
 <result pre="RotaP.A.ObersteM.S.MonroeS.S.NixW.A.CampagnoliR.IcenogleJ.P.PeÃ±arandaS.BankampB.MaherK.ChenM.-H.TongS.TaminA.LoweL.FraceM.DeRisiJ.L.ChenQ.WangD.ErdmanD.D.PeretT.C.T. â€¦BelliniW.J.Characterization of a novel coronavirus associated with severe acute" exact="respiratory" post="syndromeScience (New York, N.Y.)300562420031394139910.1126/science.1085952 SaitoA.Y.Marin RodriguezA.A.Menchaca VegaD.S.SussmannR.A.C.KimuraE.A.KatzinA.M.Antimalarial activity of"/>
 <result pre="Ebola virus host cell entry and are drug targets for" exact="disease" post="treatmentScience (New York, N.Y.)3476225201599599810.1126/science.1258758 SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for coronavirus disease"/>
 <result pre="for disease treatmentScience (New York, N.Y.)3476225201599599810.1126/science.1258758 SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for coronavirus" exact="disease" post="2019 (COVID-19): A reviewJournal of the American Medical Association3231820201824183610.1001/jama.2020.601932282022"/>
 <result pre="treatments for coronavirus disease 2019 (COVID-19): A reviewJournal of the" exact="American" post="Medical Association3231820201824183610.1001/jama.2020.601932282022 SchoemanD.FieldingB.C.Coronavirus envelope protein: Current knowledgeVirology Journal16120196910.1186/s12985-019-1182-031133031 SongJ.-G.SuJ.-C.SongQ.-Y.HuangR.-L.TangW.HuL.-J.HuangX.-J.JiangR.-W.LiY.-L.YeW.-C.WangY.Cleistocaltones"/>
 <result pre="of Aspergillus terreus for the production of natural statinsJournal of" exact="Fungi" post="(Basel, Switzerland)22201610.3390/jof2020013 SunY.WangZ.TaoJ.WangY.WuA.YangZ.WangK.ShiL.ChenY.GuoD.Yeast-based assays for the high-throughput screening of"/>
 <result pre="Pharmacology1263199967368010.1038/sj.bjp.070235710188978 UllahM.F.BhatS.H.Abu-DuhierF.M.Nutraceuticals and natural product derivatives in the premises of" exact="disease" post="preventionNutraceuticals and natural product derivatives2018John Wiley &amp;amp; Sons, Ltd10.1002/9781119436713.ch5"/>
 <result pre="domain complexed with human receptor DPP4Cell Research238201398699310.1038/cr.2013.9223835475 WanZ.LuY.LiaoQ.WuY.ChenX.Fangchinoline inhibits human" exact="immunodeficiency" post="virus type 1 replication by interfering with gp160 proteolytic"/>
 <result pre="with human receptor DPP4Cell Research238201398699310.1038/cr.2013.9223835475 WanZ.LuY.LiaoQ.WuY.ChenX.Fangchinoline inhibits human immunodeficiency virus" exact="type 1" post="replication by interfering with gp160 proteolytic processingPloS One762012e3922510.1371/journal.pone.0039225 WanL.-S.MinQ.-X.WangY.-L.YueY.-D.ChenJ.-C.Xanthone"/>
 <result pre="insights into emerging coronavirusesNature Reviews Microbiology148201652353410.1038/nrmicro.2016.8127344959 WuC.-Y.JanJ.-T.MaS.-H.KuoC.-J.JuanH.-F.ChengY.-S.E.HsuH.-H.HuangH.-C.WuD.BrikA.LiangF.-S.LiuR.-S.FangJ.-M.ChenS.-T.LiangP.-H.WongC.-H.Small molecules targeting severe" exact="acute" post="respiratory syndrome human coronavirusProceedings of the National Academy of"/>
 <result pre="into emerging coronavirusesNature Reviews Microbiology148201652353410.1038/nrmicro.2016.8127344959 WuC.-Y.JanJ.-T.MaS.-H.KuoC.-J.JuanH.-F.ChengY.-S.E.HsuH.-H.HuangH.-C.WuD.BrikA.LiangF.-S.LiuR.-S.FangJ.-M.ChenS.-T.LiangP.-H.WongC.-H.Small molecules targeting severe acute" exact="respiratory" post="syndrome human coronavirusProceedings of the National Academy of Sciences"/>
 <result pre="emerging coronavirusesNature Reviews Microbiology148201652353410.1038/nrmicro.2016.8127344959 WuC.-Y.JanJ.-T.MaS.-H.KuoC.-J.JuanH.-F.ChengY.-S.E.HsuH.-H.HuangH.-C.WuD.BrikA.LiangF.-S.LiuR.-S.FangJ.-M.ChenS.-T.LiangP.-H.WongC.-H.Small molecules targeting severe acute respiratory" exact="syndrome" post="human coronavirusProceedings of the National Academy of Sciences of"/>
 <result pre="ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.M.E.FouchierR.A.M.Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi ArabiaNew England Journal of Medicine3671920121814182010.1056/NEJMoa121172123075143 ZhangX.JiangA.QiB.MaZ.XiongY.DouJ.WangJ.Resveratrol protects"/>
 <result pre="directly inhibit 2019 novel coronavirusJournal of Integrative Medicine182202015215810.1016/j.joim.2020.02.00532113846 ZhouP.YangX.-L.WangX.-G.HuB.ZhangL.ZhangW.SiH.-R.ZhuY.LiB.HuangC.-L.ChenH.-D.ChenJ.LuoY.GuoH.JiangR.-D.LiuM.-Q.ChenY.ShenX.-R.WangX. â€¦ShiZ.-L.ZhouP.YangX.-L.WangX.-G.HuB.ZhangL.ZhangW.SiH.-R.ZhuY.LiB.HuangC.-L.ChenH.-D.ChenJ.LuoY.GuoH.JiangR.-D.LiuM.-Q.ChA" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="complex N7-Mtase N7 methyltransferase RER rough endoplasmic reticulum ERGIC ER-Golgi" exact="intermediate" post="compartment N, S M and E structural proteins N"/>
 <result pre="with the interaction of the spike glycoprotein (S) on the" exact="viral" post="coat with the receptor on the host cell membrane."/>
 <result pre="plasma membrane or by endocytosis (Phase 1: receptor binding and" exact="viral" post="entry). The viral RNA genome is released into the"/>
 <result pre="by endocytosis (Phase 1: receptor binding and viral entry). The" exact="viral" post="RNA genome is released into the cytoplasm (Phase 2:"/>
 <result pre="genome is released into the cytoplasm (Phase 2: release of" exact="viral" post="RNA genome). Translation of the viral genomic RNA produces"/>
 <result pre="(Phase 2: release of viral RNA genome). Translation of the" exact="viral" post="genomic RNA produces two large polyproteins (Phase 3: translation"/>
 <result pre="RNAs transcription). Translation of subgenomic RNAs gives rise to structural" exact="viral" post="proteins (N, S, M and E) (Phase 6: translation"/>
 <result pre="of the rough endoplasmic reticulum (RER), transported to the ERâ€&quot;Golgi" exact="intermediate" post="compartment (ERGIC) from where they combine with the RNA-encapsidated"/>
 <result pre="chemical classes of natural compounds are indicated per phase of" exact="viral" post="life cycle. Compound name, their chemical Classification, their Source,"/>
</results>
